Capital Group buys nearly 2% stake in Lotus Developers; ChrysCapital offloads over 4% stake in Corona…

New business data points to the fact that US-based Capital Group has acquired nearly 2 percent equity stake in Mumbai-based Sri Lotus Developers and Realty, while ChrysCapital-backed Sepia Investments has offloaded more than 4 percent stake in Ahmedabad-based pharmaceutical firm Corona Remedies through open-market transactions on September 10.

Lotus Developers shares appeared to react to the deal, hitting the 5 percent upper circuit at Rs 207.88 amid heavy volumes on the National Stock Exchange. In the meantime, Corona Remedies recovered sharply from a gap-down opening and ended the session at Rs 2,200.8, up 0.16 percent.

Smallcap World Fund Inc, a part of California-based Capital Group, bought 95.05 lakh equity shares, representing a 1.94 percent stake in the firm, for Rs 190.01 crore at Rs 199.89 per share.

On the other side, promoter Anand Kamalnayan Pandit was the seller in Lotus Developers, offloading 97.7 lakh shares, or a 2 percent stake, for Rs 195.3 crore at Rs 199.9 per share.

ChrysCapital affiliate offloads over 4% stake in Corona Remedies; SBI MF, Amundi buy over 3% stake

Sepia Investments, an affiliate of private equity firm ChrysCapital, sold 24.85 lakh shares, representing a 4.06 percent stake in Corona Remedies, for Rs 509.6 crore at Rs 2,050.32 per share. This was part of its total 12.68 percent stake in the firm as of June 2026.

Of the total shares sold by Sepia Investments, SBI Mutual Fund acquired 15.4 lakh shares, or a 2.51 percent stake in Corona Remedies, for Rs 315.7 crore, while Amundi Funds Asia Equity Concentrated bought 3.12 lakh shares for Rs 63.96 crore.

Both buyers acquired the shares at around Rs 2,050 per share.

Maithan Alloys picks up over half a percent stake in ESDS Software Solution

In the meantime, manganese alloys manufacturer Maithan Alloys acquired 6.34 lakh shares, representing a 0.54 percent stake in AI ecosystem provider ESDS Software Solution, for Rs 93.98 crore.

The shares were purchased at Rs 1,482.04 per share.

ESDS Software shares were locked in a 10 percent upper circuit at Rs 1,582.2 on Thursday. The stock has witnessed robust buying interest since its stock-exchange debut on September 4, consistently hitting the upper circuit.